Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Clinical trial NCT05684523 · COMPLETED
Trial details
- NCT number
- NCT05684523
- Sponsor
- Max Zeller Soehne AG
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-12-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.